Category Archives: Technology

ePharma Summit: Turning Big Data into Better Content

By Ben Comer | Published: March 6, 2013
Physicians and patients are more intimately engaged with their digital devices than ever before, but the content pharma delivers is either rigidly scientific or numbingly bland. Can stronger analytical processes and more data produce a scalable human voice for individual customers?
Also posted in Advertising, E-Media, Events, FDA, Marketing, Patient Communication, Regulatory, Sales, Strategy, healthcare, multimedia, social media | Tagged , , , , | Leave a comment

Good Gamification Isn't Child's Play

By Guest Blogger | Published: March 6, 2013
By Peter Houston. One of 2012’s biggest buzzwords was “Gamification” and that probably means that in 2013 there are a lot of people trying to sell you on the value of gamifying your pharma business. Excellent, there’s a lot of value in there, but before you head off to commission your own “Pharmaville” app, you should [...]
Also posted in Guest Blog, Op-Ed, social media | Tagged , , | 2 Comments

Trends in R&D: The Widening Gap between Success and Failure

By Clark Herman | Published: January 31, 2013
The Office of Health Economics (OHE) has released a new study examining drug development costs over the past 30 years. The study finds that out-of-pocket costs to bring a new medicine to market have increased over this period by 600%, success rates from proof of concept to registration have decreased at least twofold since the [...]
Also posted in Emerging Markets, Europe, R&D, Strategy | Tagged | 1 Comment

It's Blind Leading the Blind on Companion Diagnostics

By Clark Herman | Published: January 25, 2013
A new report from the Tufts Center for Study of Drug Development (CSDD), confirms that companion diagnostics are an important factor for pharma companies to consider when seeking reimbursement of their drugs. But companies still have a ways to go in allaying the concerns of investors, regulators and payors alike, and fixing this will require [...]
Also posted in FDA, Orphan Drugs, R&D, Regulatory, Strategy | Tagged | Leave a comment

Pharma's Promotional Spend: What's the Right Target?

By Clark Herman | Published: January 17, 2013
Global consultancy Cegedim has released its latest survey on how and where big Pharma puts its promotional dollar. Pharmaceutical Promotional Spend: Global Trends reports that spending in emerging markets significantly increased last year, while Europe and US declined slightly.  Although overall promotion spending remained flat worldwide at $90 billion, the US still accounts for the [...]
Also posted in Advertising, Emerging Markets, Europe, Global, Marketing, Meetings, Sales, Strategy, social media | Tagged , , , , , | Leave a comment